![]() VLVbio VLVbio is a company devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology. | ![]() 3D Medicines 3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs. | ![]() Singleron Biotechnologies Singleron Biotechnolgies (formerly Proteona)is a biotechnology company that provides a genomic and proteomic analysis platform. | ![]() Stratify Genomics Stratify Genomics' flagship test, Prompt, evaluates a man’s genetic predisposition to prostate cancer. | ||
Founding Date | Founding Date 2013 | Founding Date 2010 | Founding Date 2017 | Founding Date 2007 | Founding Date N/A |
Type | Type Private | Type Private | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Shanghai, CN HQ Singapore, SG Dubai, AE Fremont, US | Locations Singapore, SG HQ | Locations Rockville, US HQ Rockville, US | Locations San Diego, US HQ |
Employees | Employees 9 | Employees 70030% decrease | Employees 109% decrease | Employees 284% increase | Employees 5 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 140m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 340k (over 11 years ago) | Latest funding round $ 2.2m (almost 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 281m | Total funding raised N/A | Total funding raised $ 1.6m | Total funding raised $ 2.2m |

3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs.
View company
Singleron Biotechnolgies (formerly Proteona)is a biotechnology company that provides a genomic and proteomic analysis platform.
View companyAmerican Gene Technologies (AGT) is a gene and cell therapeutics company.
View company
Stratify Genomics' flagship test, Prompt, evaluates a man’s genetic predisposition to prostate cancer.
View company